Oppenheimer Reiterates Outperform Rating, $16 Price Target on Milestone Pharmaceuticals (MIST), "We Like Risk/Reward into RAPID Trial Readout"

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. CRWD
2. AVGO
3. VEEV
4. SPY
5. FIVE
6. NTSK
7. PLTR
8. VRTS
9. AI
10. MDT

Go back to Oppenheimer Reiterates Outperform Rating, $16 Price Target on Milestone Pharmaceuticals (MIST), "We Like Risk/Reward into RAPID Trial Readout"
(NASDAQ: MIST) Delayed: 1.29 +0.01 (0.78%)
Previous Close $1.28    52 Week High $ 
Open $1.29    52 Week Low $ 
Day High $1.34    P/E N/A 
Day Low $1.28    EPS $ 
Volume 857,948